Antiseizure medication adherence and epilepsy surgery attitude in people with epilepsy in Morocco: A cross-sectional study

• Published in: Epilepsy & behavior reports 2024-01, Vol.26, p.100672-100672, Article 100672
• Main Authors: Hajji, El Bachir, Traore, Boubacar, Hassoune, Samira, Bellakhdar, Salma, Rafai, Mohammed Abdoh, Lakhdar, Abdelhakim
• Format: Article
• Language: English
• Subjects: Adherence; Epilepsy; Factors; Morocco; Surgery
• ISSN: 2589-9864; 2589-9864
• DOI: 10.1016/j.ebr.2024.100672

•The proportion of non-AMA was 24.5 % and indifference was the main reason (55.6 %).•ES refusal was found in 33.3 %, attributed mostly to apprehension (61.2 %).•Male sex and family history of epilepsy were the associated factors for the non-AMA.•Allopathic therapies were the sole behavioral factor associated with the ES refusal.•Clinically, ES refusal was associated with non-combined seizures and generic ASM. We determine the proportion of non-Antiseizure Medication Adherence (non-AMA) and refusal attitude towards Epilepsy Surgery (ES) and their associated factors in Moroccan People With Epilepsy (PWE). A cross-sectional study was conducted (December 2021-December 2022) among adult Moroccan PWE. PWE were interviewed for their reactions to AMA and the ES attitude. Their medical files were processed to complete their sociodemographic and clinical data. Data were analyzed by the Statistical Package for Social Sciences (SPSS) software 21.0. A Chi-square test was performed to compare variables and multivariate logistic regression was used to highlight associations. Statistical tests were considered significant at a p-value ≤ 0.05 for a Confidence Interval (CI) of 95 %. The median age of our sample (n = 294) was 38 years (IQR: 25.00–55.00). Non-AMA was noted in 24.5 % with indifference as the main reason (55.6 %). ES refusal was found in 33.3 %, attributed mostly to apprehension (61.2 %). In the multivariate analysis, male sex (aOR = 1.94; 95 %CI: 1.03–3.64) and the existence of a family history of epilepsy (aOR = 1.96; 95 %CI: 1.02–3.75) were the factors associated with the non-AMA, whereas the use of allopathic treatments (aOR = 2.32; 95 %CI: 1.20–4.51), exclusively focal or generalized (not combined) seizures (aOR = 2.66; 95 %CI: 1.36–5.21) and the combination of a generic with the originator ASM (aOR = 2.64; 95 %CI: 1.12–6.18) were the predictive factors with the ES refusal attitude. The proportions found of non-AMA and ES refusal were relatively low compared to other studies, which may indicate the effort that medical staff have devoted recently to raising awareness of the importance of PWE’s therapeutic involvement.